| CsA | cyclosporine A |
| cTnT | cardiac troponin T |
| FS | fractional shortening |
| hAFSC | human amniotic fluid-derived stem cell |
| hAFSC-iPSC | human amniotic fluid-derived stem cell induced pluripotent stem cell |
| hAFSC-iPSC-CM | human amniotic fluid-derived stem cell induced pluripotent stem cell derived cardiomyocyte |
| hESC | human embryonic stem cell |
| HLA | human leukocyte antigen |
| hPSC | human pluripotent stem cell |
| hPSC-CM | human pluripotent stem cell derived cardiomyocyte |
| I Ca,L | L-type Ca2+ current |
| I Na | Na+ current |
| iPSC | induced pluripotent stem cell |
| I-R | ischemia-reperfusion |
| LAD | left anterior descending coronary artery |
| LV | left ventricular |
| LVEDD | left ventricular end-diastolic diameter |
| LVEDS | left ventricular end-diastolic volume |
| LVEF | left ventricular ejection fraction |
| LVESD | left ventricular end-systolic diameter |
| LVESV | left ventricular end-systolic volume |
| MHC | major histocompatibility complex |
| MI | myocardial infarction |
| OCT-4 | octamer-binding transcription factor 4 |
| SSEA4 | Nanog and stage-specific embryonic antigen-4 |